financetom
Business
financetom
/
Business
/
The Making: How to bridge the MSME credit gap? Experts weigh in
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
The Making: How to bridge the MSME credit gap? Experts weigh in
Mar 11, 2021 12:01 PM

The contribution of MSMEs to India's economic story is undeniable. The COVID-19 pandemic has had a severe impact on India's economy with MSMEs being the worst hit.

An analysis of the latest bank credit growth data from the Reserve Bank of India shows credit offtake in the MSME sector suffered a steep year on year contraction of 12.7 percent for June 2020 alone.

While loans to micro and small industries shrank 7.6 percent, for medium-sized industries they dipped by 9.4 percent.

The key catalyst to the MSME growth story is access to finance and access to formal credit in particular. The industry remains chronically underserved.

The World Bank estimates the current credit gap for Indian MSMEs is at $380 billion.

CNBC-TV18's Shereen Bhan spoke to Shreekant Somany, chairman of CII - National MSME Council, CMD at Somany Ceramics; Vaibhav Gupta, co-founder of Udaan and Rajat Verma, MD & head of commercial banking at HSBC India to discuss the ways to address the MSME financing gap.

Watch the video for more.

(Edited by : Abhishek Jha)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Wellchange Holdings Prices IPO
Wellchange Holdings Prices IPO
Oct 2, 2024
04:45 AM EDT, 10/02/2024 (MT Newswires) -- Wellchange Holdings said late Tuesday it priced its initial public offering of 2 million shares at $4 per share. Of the 2 million shares, 1.1 million are being offered by the company, while the remaining 900,000 are being offered by a selling shareholder. The company expects to raise gross proceeds of $4.4 million...
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Oct 2, 2024
(Reuters) - Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning contingent value rights (CVR) because...
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Oct 2, 2024
Sept 30 (Reuters) - Bristol Myers Squibb ( BMY ) won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning...
--Street Color: Lionsgate Offering US Employees Voluntary Severance, Early Retirement Program, Deadline Reports
--Street Color: Lionsgate Offering US Employees Voluntary Severance, Early Retirement Program, Deadline Reports
Oct 2, 2024
02:40 PM EDT, 09/30/2024 (MT Newswires) -- Price: 7.14, Change: -0.15, Percent Change: -2.06 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved